Search clinical trials for: Dasatinib Maximum Tolerated Dose
Total 86 results
-
University of NebraskaBristol-Myers SquibbCompleted
-
Hellenic Institute for the Study of SepsisCompletedVirus Diseases | COVID-19 | Corona Virus Infection | Lower Respiratory Tract Infection ViralGreece
-
National Taiwan University HospitalCompletedNon-Small Cell Lung CancerTaiwan
-
Immunobiology Research InstituteCompletedHIV InfectionsUnited States
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLCTerminatedMetastatic Non-small-cell lunG CancerUnited Kingdom
-
Medical College of WisconsinMiltenyi Biomedicine GmbHActive, not recruitingB-cell Chronic Lymphocytic Leukemia | B-cell Non Hodgkin LymphomaUnited States
-
Sunhawk Vision Biotech, Inc.Completed
-
McMaster UniversityMediPharm Labs CorpWithdrawnGeneralized Anxiety Disorder | Social Anxiety Disorder | Panic Disorder | AgoraphobiaCanada
-
Millennium Pharmaceuticals, Inc.CompletedDigestive System DiseaseUnited States
-
Merck Sharp & Dohme LLCRecruitingNosocomial PneumoniaUnited States, Estonia, Greece, Spain, Ukraine, Chile, Russian Federation, Colombia, Mexico
-
Dr. Rajendra Prasad Government Medical CollegeUnknownCancer | Excessive Sleepiness | Pain PalliationIndia
-
Dawonmedax Co., Ltd.RecruitingRecurrent Glioblastoma | Recurrent High-grade Glioma | Recurrent Anaplastic Astrocytoma | Recurrent Anaplastic OligodendrogliomaKorea, Republic of
-
Jonsson Comprehensive Cancer CenterPfizerCompleted
-
Medical College of WisconsinNot yet recruiting
-
Gamaleya Research Institute of Epidemiology and...Acellena Contract Drug Research and DevelopmentRecruitingUrinary Tract Infections | Pseudomonas Infections | Pseudomonas Aeruginosa | Patients With Complicated Urinary Tract Infections Caused by P. AeruginosaRussian Federation
-
University Health Network, TorontoCompletedNon-small Cell Lung CancerCanada
-
AIO-Studien-gGmbHDeutsche Krebshilfe e.V., Bonn (Germany)RecruitingChemo-refractory Colorectal CarcinomaGermany
-
Medical College of WisconsinBarbara Ann Karmanos Cancer Institute; Cornerstone PharmaceuticalsRecruitingPancreas AdenocarcinomaUnited States
-
CytoDyn, Inc.Amarex Clinical ResearchActive, not recruitingTriple Negative Breast NeoplasmsUnited States
-
University of PatrasCompleted
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Israel
-
Hospices Civils de LyonCompletedCystic Fibrosis-related Diabetes
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Spain, Israel, Canada, Belgium, United Kingdom, France, Tunisia
-
Merck Sharp & Dohme LLCCompleted
-
Janssen Research & Development, LLCCompletedColitis, UlcerativeUnited States, Russian Federation, Australia, Poland, Germany, Brazil, Ukraine, Argentina, Mexico
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Korea, Republic of, Spain
-
Bio-Path Holdings, Inc.WithdrawnAcute Myeloid Leukemia | Myelodysplastic Syndrome | Chronic Myelogenous Leukemia, Ph1-PositiveUnited States
-
University of ZurichTerminated
-
Abramson Cancer Center of the University of PennsylvaniaCompletedHead and Neck Cancer | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent... and other conditionsUnited States
-
GlaxoSmithKlineCompletedNeoplasms, Head and NeckSpain, Estonia, Italy, Philippines, Thailand, Germany, United States, Hong Kong, Ireland, China, United Kingdom, Argentina, Austria, Russian Federation, Czech Republic, Hungary, India, France, Canada, Croatia, Greece, Slovakia
-
AHS Cancer Control AlbertaTom Baker Cancer CentreRecruitingGlioblastoma | Recurrent Glioblastoma | Recurrent DiseaseCanada
-
University of PennsylvaniaWithdrawnBreast CancerUnited States
-
M.D. Anderson Cancer CenterElevar TherapeuticsNot yet recruitingMetastatic Olfactory Neuroblastoma | Recurrent Olfactory NeuroblastomaUnited States
-
Boehringer IngelheimCompleted
-
Charite University, Berlin, GermanyThe Volkswagen FoundationCompleted
-
University of Maryland, BaltimoreCompletedRisk ReductionUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Institut CurieUnknownReccurent/Metastatic Solid Tumor DiseaseFrance
-
Novartis PharmaceuticalsCompleted
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruitingPrecursor Cell Lymphoblastic Leukemia-Lymphoma | ALL, Adult | Philadelphia-Positive Acute Lymphoblastic LeukemiaChina
-
Boehringer IngelheimCompleted
-
University of Texas Southwestern Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)CompletedHypertensionUnited States
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey ClinicCompleted
-
Memorial Sloan Kettering Cancer CenterBristol-Myers SquibbCompletedLeukemia | Acute Lymphoblastic LeukemiaUnited States
-
Assistance Publique - Hôpitaux de ParisAction Research GroupTerminatedDepression | Coronary Artery DiseaseFrance
-
German Breast GroupGlaxoSmithKline; Roche Pharma AG; Teva Pharmaceuticals USACompletedInflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IVGermany
-
GlaxoSmithKlineCompleted
-
Eskisehir Osmangazi UniversityCompleted